Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Copy number profile of human prostate cancer organoid lines using Agilent 1M aCGH platform

ABSTRACT: Advanced prostate cancer is a highly heterogenous disease with few in vitro models. We report generation of seven novel 3D organoid lines of patient-derived prostate cancer. We determine the copy number alterations of these lines using array CGH. They contain may classic alterations of prostate cancer such as lost of the short arm of chromosome 8 and gain of the long arm of chromosome 8. In addition, we found homozygous deleteion of tumor suppressor PTEN and CHD1 as well as the TMPRSS2-ERG interstitial deletion. Prostate cancer organoid lines, ~2 months after in vitro propagation, were used for profiling on Agilent 1M aCGH arrays per manufacturer's instructions. A pooled reference normal DNA was used as the reference.

ORGANISM(S): Homo sapiens

SUBMITTER: Yu Chen 

PROVIDER: E-GEOD-60612 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Organoid cultures derived from patients with advanced prostate cancer.

Gao Dong D   Vela Ian I   Sboner Andrea A   Iaquinta Phillip J PJ   Karthaus Wouter R WR   Gopalan Anuradha A   Dowling Catherine C   Wanjala Jackline N JN   Undvall Eva A EA   Arora Vivek K VK   Wongvipat John J   Kossai Myriam M   Ramazanoglu Sinan S   Barboza Luendreo P LP   Di Wei W   Cao Zhen Z   Zhang Qi Fan QF   Sirota Inna I   Ran Leili L   MacDonald Theresa Y TY   Beltran Himisha H   Mosquera Juan-Miguel JM   Touijer Karim A KA   Scardino Peter T PT   Laudone Vincent P VP   Curtis Kristen R KR   Rathkopf Dana E DE   Morris Michael J MJ   Danila Daniel C DC   Slovin Susan F SF   Solomon Stephen B SB   Eastham James A JA   Chi Ping P   Carver Brett B   Rubin Mark A MA   Scher Howard I HI   Clevers Hans H   Sawyers Charles L CL   Chen Yu Y  

Cell 20140904 1

The lack of in vitro prostate cancer models that recapitulate the diversity of human prostate cancer has hampered progress in understanding disease pathogenesis and therapy response. Using a 3D organoid system, we report success in long-term culture of prostate cancer from biopsy specimens and circulating tumor cells. The first seven fully characterized organoid lines recapitulate the molecular diversity of prostate cancer subtypes, including TMPRSS2-ERG fusion, SPOP mutation, SPINK1 overexpress  ...[more]

Similar Datasets

Genomics Copy number profile of human prostate cancer organoid lines using Agilent 1M aCGH platform
2014-09-09 | GSE60612 | GEO
Transcriptomics Copy number alteration burden predicts prostate cancer relapse: Agilent 1M aCGH data for human primary prostate cancer samples
2014-06-30 | E-GEOD-54691 | biostudies-arrayexpress
Transcriptomics Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma (DDLS) part 2
2013-09-24 | E-GEOD-50750 | biostudies-arrayexpress
Proteomics An Integrative Transcriptome – Proteome Approach Reveals a Robust Expression Pattern of Small Intestinal Epithelial Organoids from Germ-Free and Microbiota Associated Donors
2020-03-05 | PXD016339 | Pride
Genomics ATAC-Seq of MSK-PCa series of Patient Derived Organoids and Xenografts, and prostate cell lines
2022-01-21 | GSE193917 | GEO
Transcriptomics Affymetrix SNP array data for soft tissue sarcoma samples
2010-07-05 | E-GEOD-21123 | biostudies-arrayexpress
Transcriptomics Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy
2010-07-05 | E-GEOD-21124 | biostudies-arrayexpress
Transcriptomics Primary prostate organoid transcriptomic profile in co-culture with primary prostate stroma
2018-05-30 | GSE115052 | GEO
Transcriptomics Analysis of mouse enteroids and colonoids exposed to chemotherapy agent 5-fluorouracil (5FU)
2023-09-29 | E-MTAB-9119 | biostudies-arrayexpress
Transcriptomics Analysis of human enteroids and colonoids (3D organoid models from small intestine and colon) exposed to chemotherapy agent and tyrosine kinase inhibitor (TKI) gefitinib sampled at four doses (0.1, 1, 10 and 30uM) and at three time points (24, 48 and 72h) since initial exposure
2022-04-11 | E-MTAB-11221 | biostudies-arrayexpress